Free-cash-flow proxy decreased 33.8%
Free-cash-flow proxy changed -33.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.2B→$1.4B2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AMP financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow decreased 33.3%
Operating cash flow changed -33.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.2B→$1.5B2 prior comparisons
Shares outstanding decreased 6.6%
Shares outstanding changed -6.6% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
92,905,713→86,812,4698 prior comparisons
Net income increased 23.5%
Net income changed +23.5% from the comparable as-filed period.
$912.0M→$1.1B2 prior comparisons
Free-cash-flow margin moved 1662 bp lower
Free-cash-flow margin changed -1662 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
44.14%→27.53%2 prior comparisons
Operating cash flow / net income decreased 45.9%
Operating cash flow / net income changed -45.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.42→1.312 prior comparisons
Operating cash-flow margin moved 1671 bp lower
Operating cash-flow margin changed -1671 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
45.04%→28.34%2 prior comparisons
Revenue increased 6.1%
Revenue changed +6.1% from the comparable as-filed period.
$4.9B→$5.2B2 prior comparisons
Capex / revenue moved 9 bp lower
Capex / revenue changed -9 basis points from the comparable as-filed period.
0.90%→0.81%2 prior comparisons
Total assets increased 0.7%
Total assets changed +0.7% from the comparable as-filed period.
$190.1B→$191.4B3 prior comparisons
SBC / revenue moved 2 bp higher
SBC / revenue changed +2 basis points from the comparable as-filed period.
1.02%→1.04%2 prior comparisons
Stock-based compensation increased 8.0%
Stock-based compensation changed +8.0% from the comparable as-filed period.
$50.0M→$54.0M2 prior comparisons
Capital expenditure decreased 4.5%
Capital expenditure changed -4.5% from the comparable as-filed period.
$44.0M→$42.0M2 prior comparisons
Free-cash-flow proxy increased 65.1%
Free-cash-flow proxy changed +65.1% from the comparable as-filed period.
$1.7B→$2.8B3 prior comparisons
Operating cash flow increased 63.6%
Operating cash flow changed +63.6% from the comparable as-filed period.
$1.8B→$2.9B3 prior comparisons
Shares outstanding decreased 6.3%
Shares outstanding changed -6.3% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
94,271,565→88,333,2198 prior comparisons
Revenue increased 11.6%
Revenue changed +11.6% from the comparable as-filed period.
$4.5B→$5.0B2 prior comparisons
Operating cash flow / net income increased 55.8%
Operating cash flow / net income changed +55.8% from the comparable as-filed period.
1.66→2.592 prior comparisons
Free-cash-flow margin moved 1839 bp higher
Free-cash-flow margin changed +1839 basis points from the comparable as-filed period.
38.44%→56.83%2 prior comparisons
Operating cash-flow margin moved 1828 bp higher
Operating cash-flow margin changed +1828 basis points from the comparable as-filed period.
39.29%→57.57%2 prior comparisons
Net income increased 5.0%
Net income changed +5.0% from the comparable as-filed period.
$1.1B→$1.1B2 prior comparisons
Total assets increased 7.0%
Total assets changed +7.0% from the comparable as-filed period.
$184.9B→$197.9B3 prior comparisons
Capex / revenue moved 11 bp lower
Capex / revenue changed -11 basis points from the comparable as-filed period.
0.85%→0.74%2 prior comparisons
SBC / revenue moved 3 bp lower
SBC / revenue changed -3 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.02%→1.00%2 prior comparisons
Capital expenditure decreased 2.6%
Capital expenditure changed -2.6% from the comparable as-filed period.
$38.0M→$37.0M3 prior comparisons
Stock-based compensation increased 8.7%
Stock-based compensation changed +8.7% from the comparable as-filed period.
$46.0M→$50.0M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.